The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Metallo-β-Lactamases: the Quiet before the Storm?
Open accessAbstract
SUMMARY: The ascendancy of metallo-β-lactamases within the clinical sector, while not ubiquitous, has nonetheless been dramatic; some reports indicate that nearly 30% of imipenem-resistant Pseudomonas aeruginosa strains possess a metallo-β-lactamase. Acquisition of a metallo-β-lactamase gene will invariably mediate broad-spectrum β-lactam resistance in P. aeruginosa, but the level of in vitro resistance in Acinetobacter spp. and Enterobacteriaceae is less dependable. Their clinical significance is further embellished by their ability to hydrolyze all β-lactams and by the fact that there is currently no clinical inhibitor, nor is there likely to be for the foreseeable future. The genes encoding metallo-β-lactamases are often procured by class 1 (sometimes class 3) integrons, which, in turn, are embedded in transposons, resulting in a highly transmissible genetic apparatus. Moreover, other gene cassettes within the integrons often confer resistance to aminoglycosides, precluding their use as an alternative treatment. Thus far, the metallo-β-lactamases encoded on transferable genes include IMP, VIM, SPM, and GIM and have been reported from 28 countries. Their rapid dissemination is worrisome and necessitates the implementation of not just surveillance studies but also metallo-β-lactamase inhibitor studies securing the longevity of important anti-infectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
SOS response promotes horizontal dissemination of antibiotic resistance genes
Beaber, J. W., Hochhut, B., & Waldor, M. K. (2004) · Nature · doi:10.1038/nature02241 · Cited by 1,186
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Self-citationNeuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
Transferable imipenem resistance in Pseudomonas aeruginosa
Watanabe, M., Iyobe, S., Inoue, M., & Mitsuhashi, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.147 · Cited by 619
Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J.-D., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.891-897.2000 · Cited by 562
Self-citationYong, D., Lee, K., Yum, J. H., Shin, H. B., Rossolini, G. M., & Chong, Y. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3798-3801.2002 · Cited by 538
Why is big Pharma getting out of antibacterial drug discovery?
Projan, S. J. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.003 · Cited by 503
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Senda, K., Arakawa, Y., Ichiyama, S., Nakashima, K., Ito, H., Ohsuka, S., Shimokata, K., Kato, N., & Ohta, M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2909-2913.1996 · Cited by 416
Standard Numbering Scheme for Class B β-Lactamases
Galleni, M., Lamotte-Brasseur, J., Rossolini, G. M., Spencer, J., Dideberg, O., Frère, J.-M., & The Metallo-β-Lactamase Working Group (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.660-663.2001 · Cited by 414
Eliopoulos, G. M., & Bush, K. (2001) · Clinical Infectious Diseases · doi:10.1086/319610 · Cited by 392
Carbapenem-hydrolyzing beta-lactamases
Rasmussen, B. A., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.223 · Cited by 361
Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis
Concha, N. O., Rasmussen, B. A., Bush, K., & Herzberg, O. (1996) · Structure · doi:10.1016/s0969-2126(96)00089-5 · Cited by 359
Perron, K., Caille, O., Rossier, C., van Delden, C., Dumas, J.-L., & Köhler, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312080200 · Cited by 358
Ullah, J. H., Walsh, T. R., Taylor, I. A., Emery, D. C., Verma, C. S., Gamblin, S. J., & Spencer, J. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2148 · Cited by 337
Self-citationToleman, M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf210 · Cited by 327
Self-citationCarbapenemases: a problem in waiting?
Livermore, D. M., & Woodford, N. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00128-4 · Cited by 323
A novel integron-like element carrying the metallo-beta-lactamase gene blaIMP
Arakawa, Y., Murakami, M., Suzuki, K., Ito, H., Wacharotayankun, R., Ohsuka, S., Kato, N., & Ohta, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1612 · Cited by 311
Concha, N. O., Janson, C. A., Rowling, P., Pearson, S., Cheever, C. A., Clarke, B. P., Lewis, C., Galleni, M., Frère, J.-M., Payne, D. J., et al. (2000) · Biochemistry · doi:10.1021/bi992569m · Cited by 307
Expansion of the zinc metallo‐hydrolase family of the β‐lactamase fold
Daiyasu, H., Osaka, K., Ishino, Y., & Toh, H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02686-2 · Cited by 304
Update of the Standard Numbering Scheme for Class B β-Lactamases
Garau, G., García-Sáez, I., Bebrone, C., Anne, C., Mercuri, P., Galleni, M., Frère, J.-M., & Dideberg, O. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2347-2349.2004 · Cited by 286
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Markou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Senda, K., Arakawa, Y., Nakashima, K., Ito, H., Ichiyama, S., Shimokata, K., Kato, N., & Ohta, M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.349 · Cited by 275
Metallo-β-lactamase: structure and mechanism
Wang, Z., Fast, W., Valentine, A. M., & Benkovic, S. J. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00017-4 · Cited by 275
Ito, H., Arakawa, Y., Ohsuka, S., Wacharotayankun, R., Kato, N., & Ohta, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.824 · Cited by 266
Beta‐lactamases and bacterial resistance to antibiotics
Frère, J. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02404.x · Cited by 263
Castanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., & Walsh, T. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4654-4661.2004 · Cited by 261
Self-citationLinden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
Riccio, M. L., Franceschini, N., Boschi, L., Caravelli, B., Cornaglia, G., Fontana, R., Amicosante, G., & Rossolini, G. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1229-1235.2000 · Cited by 249
Bou, G., Oliver, A., & Martínez-Beltrán, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1556-1561.2000 · Cited by 247
Gales, A. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg416 · Cited by 242
Toney, J. H., Fitzgerald, P. M. D., Grover-Sharma, N., Olson, S. H., May, W. J., Sundelof, J. G., Vanderwall, D. E., Cleary, K. A., Grant, S. K., Wu, J. K., et al. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90632-9 · Cited by 241
Laraki, N., Franceschini, N., Rossolini, G. M., Santucci, P., Meunier, C., de Pauw, E., Amicosante, G., Frère, J. M., & Galleni, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.902 · Cited by 233
Garau, G., Bebrone, C., Anne, C., Galleni, M., Frère, J.-M., & Dideberg, O. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.070 · Cited by 231
GES-2, a Class A β-Lactamase from Pseudomonas aeruginosa with Increased Hydrolysis of Imipenem
Poirel, L., Weldhagen, G. F., Naas, T., De Champs, C., Dove, M. G., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2598-2603.2001 · Cited by 228
Self-citationRasmussen, B. A., Bush, K., Keeney, D., Yang, Y., Hare, R., O'Gara, C., & Medeiros, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2080 · Cited by 217
Urban, C., Segal‐Maurer, S., & Rahal, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/374847 · Cited by 211
Metallo‐β‐Lactamases: A Class Apart
Bush, K. (1998) · Clinical Infectious Diseases · doi:10.1086/514922 · Cited by 205
Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase
Toney, J. H., Hammond, G. G., Fitzgerald, P. M. D., Sharma, N., Balkovec, J. M., Rouen, G. P., Olson, S. H., Hammond, M. L., Greenlee, M. L., & Gao, Y.-D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104742200 · Cited by 201
Integrons and gene cassettes: a genetic construction kit for bacteria
Bennett, P. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.1 · Cited by 186
On the Mechanism of the Metallo-β-lactamase from Bacteroides fragilis
Wang, Z., Fast, W., & Benkovic, S. J. (1999) · Biochemistry · doi:10.1021/bi990356r · Cited by 178
Gibb, A. P., Tribuddharat, C., Moore, R. A., Louie, T. J., Krulicki, W., Livermore, D. M., Palepou, M.-F. I., & Woodford, N. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.255-258.2002 · Cited by 169
On functional and structural heterogeneity of VIM-type metallo-beta-lactamases
Docquier, J.-D. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg067 · Cited by 167
Toleman, M. A., Rolston, K. V., Jones, R. N., & Walsh, T. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.329-332.2004 · Cited by 167
Self-citationThompson, J. S., & Malamy, M. H. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.5.2584-2593.1990 · Cited by 164
Yang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 163
Nordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas, M. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
Self-citationYano, H., Kuga, A., Okamoto, R., Kitasato, H., Kobayashi, T., & Inoue, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1343-1348.2001 · Cited by 152
Garcia-Saez, I., Hopkins, J., Papamicaël, C. A., Franceschini, N., Amicosante, G., Rossolini, G. M., Galleni, M., Frère, J., & Dideberg, O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301062200 · Cited by 149
Avison, M. B., Higgins, C. S., von Heldreich, C. J., Bennett, P. M., & Walsh, T. R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.413-419.2001 · Cited by 146
Self-citationGarcia-Saez, I., Mercuri, P. S., Papamicaël, C. A., Kahn, R., Frère, J.-M., Galleni, M., Rossolini, G. M., & Dideberg, O. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01271-8 · Cited by 131
Poirel, L., Magalhães, M., Lopes, M., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1406-1409.2004 · Cited by 130
Self-citationHéritier, C., Poirel, L., Aubert, D., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.268-273.2003 · Cited by 129
Self-citationQueenan, A. M., Torres‐Viera, C., Gold, H. S., Carmeli, Y., Eliopoulos, G. M., Moellering, R. C., Quinn, J. P., Hindler, J. F., Medeiros, A. A., & Bush, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3035-3039.2000 · Cited by 128
Iwanaga, M., Toma, C., Miyazato, T., Insisiengmay, S., Nakasone, N., & Ehara, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2364-2369.2004 · Cited by 126 · cited 1×
“terium was exposed to fluoroquinolones (9, 67).”
Partridge, S. R., & Hall, R. M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.21.6371-6384.2003 · Cited by 126
Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives
Payne, D. J., Bateson, J. H., Gasson, B. C., Proctor, D. G., Khushi, T., Farmer, T. H., Tolson, D., Bell, D., Skett, P. W., MARSHALL, A. C., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.135 · Cited by 123
Walsh, T. R., MacGowan, A. P., & Bennett, P. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1460 · Cited by 121
Self-citationβ-Lactamase Genes of the Penicillin-SusceptibleBacillus anthracisSterne Strain
Chen, Y., Succi, J., Tenover, F. C., & Koehler, T. M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.823-830.2003 · Cited by 118
Thiomandelic Acid, a Broad Spectrum Inhibitor of Zinc β-Lactamases
Mollard, C., Moali, C., Papamicaël, C. A., Damblon, C., Vessilier, S., Amicosante, G., Schofield, C. J., Galleni, M., Frère, J., & Roberts, G. C. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107054200 · Cited by 118
Andrade, S. S. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg270 · Cited by 117
N-Arylsulfonyl Hydrazones as Inhibitors of IMP-1 Metallo-β-Lactamase
Siemann, S., Evanoff, D. P., Marrone, L., Clarke, A. J., Viswanatha, T., & Dmitrienko, G. I. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2450-2457.2002 · Cited by 112
1.85 Å Resolution Structure of the ZincII β-Lactamase from Bacillus cereus
Carfı́, A., Duée, E. D., Galleni, M., Frère, J., & Dideberg, O. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444997010627 · Cited by 110
Luzzaro, F., Docquier, J., Colinon, C., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.648-650.2004 · Cited by 109
Payne, D. J., Hueso-Rodríguez, J. A., Boyd, H., Concha, N. O., Janson, C. A., Gilpin, M. L., Bateson, J. H., Cheever, C. A., Niconovich, N. L., Pearson, S. C., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1880-1886.2002 · Cited by 109
Pournaras, S., Tsakris, A., Maniati, M. A., TZOUVELEKIS, L. S., & Maniatis, A. N. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.4026-4028.2002 · Cited by 108
Scrofani, S. D. B., Chung, J., Huntley, J. J. A., Benkovic, S. J., Wright, P. E., & Dyson, H. J. (1999) · Biochemistry · doi:10.1021/bi990986t · Cited by 99
Houang, E. T. S., Chu, Y.-W., Lo, W. U., Chu, K. Y., & Cheng, A. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1382-1390.2003 · Cited by 99
Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases
Walter, M. W., Felici, A., Galleni, M., Soto, R. P., Adlington, R. M., Baldwin, J. E., Frère, J., Gololobov, M. Y., & Schofield, C. J. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00453-2 · Cited by 91
SPENCER, J. M., Clarke, A. R., & Walsh, T. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105550200 · Cited by 90
Self-citationRossolini, G. M., Condemi, M. A., Pantanella, F., Docquier, J., Amicosante, G., & Thaller, M. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.837-844.2001 · Cited by 84
Conejo, M. C., Garcı́a, I., Martı́nez-Martı́nez, L., Picabea, L., & Pascual, Á. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2313-2315.2003 · Cited by 81
Penicillin-derived inhibitors that simultaneously target both metallo- and serine-β-lactamases
Buynak, J. D., Chen, H., Vogeti, L., Gadhachanda, V. R., Buchanan, C. A., Palzkill, T. G., Shaw, R. W., SPENCER, J. M., & Walsh, T. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.037 · Cited by 77
Self-citationOh, E., Lee, S., Park, Y.-J., et al. (2003) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(03)00090-3 · Cited by 76
Collis, C. M., Kim, M., Stokes, H. W., & Hall, R. M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03260.x · Cited by 75
β-Lactamase-inhibitor combinations in the 21st century: current agents and new developments
Miller, L. A., Ratnam, K., & Payne, D. J. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00079-0 · Cited by 75
Sfh-I, a Subclass B2 Metallo-β-Lactamase from a Serratia fonticola Environmental Isolate
Saavedra, M. J., Peixe, L. M. S. V., Sousa, J. C., Henriques, I. S., Alves, A., & Correia, A. C. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2330-2333.2003 · Cited by 75
Yamasaki, K., Komatsu, M., Yamashita, T., Shimakawa, K., Ura, T., Nishio, H., Satoh, K., Washidu, R., Kinoshita, S., & Aihara, M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg103 · Cited by 74
Nagano, R., Adachi, Y., Imamura, H., Yamada, K., Hashizume, T., & Morishima, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2497 · Cited by 69
Docquier, J., Pantanella, F., Giuliani, F., Thaller, M. C., Amicosante, G., Galleni, M., Frère, J., Bush, K., & Rossolini, G. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1823-1830.2002 · Cited by 67
X-ray Structure of the ZnII β-Lactamase from Bacteroides fragilis in an Orthorhombic Crystal Form
Carfı́, A., Duée, E. D., Soto, R. P., Galleni, M., Frère, J., & Dideberg, O. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744499700927x · Cited by 66
Detection of VIM-5 metallo- -lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey
Bahar, G., Mazzariol, A., Koncan, R., Mert, A., Fontana, R., Rossolini, G. M., & Cornaglia, G. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh321 · Cited by 65
A new integron carrying VIM-2 metallo-β-lactamase gene cassette in a Serratia marcescens isolate
Yum, J. H., Yong, D., Lee, K., Kim, H.-S., & Chong, Y. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00352-2 · Cited by 61
A zinc-binding motif conserved in glyoxalase II, β-lactamase and arylsulfatases
Melino, S., Capo, C. R., Dragani, B., Aceto, A., & Petruzzelli, R. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01264-x · Cited by 60
Libisch, B., Gacs, M., Csiszár, K., Muzslay, M., Rókusz, L., & Füzi, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3576-3578.2004 · Cited by 55
Emergence of IMP-4 metallo-β-lactamase in a clinical isolate from Australia
Peleg, A. Y., Franklin, C., Bell, J. M., & Spelman, D. W. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh398 · Cited by 48
Rapid identification of metallo- and serine beta-lactamases
Payne, D. J., Cramp, R., Bateson, J. H., NEALE, J. E., & KNOWLES, D. J. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.991 · Cited by 46
Overcoming multidrug resistance in gram-negative bacteria.
Poole, K. (2003) · PubMed · Cited by 45
IMP-1 and a Novel Metallo-β-Lactamase, VIM-6, in Fluorescent Pseudomonads Isolated in Singapore
Koh, T. H., Wang, G. C. Y., & Sng, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2334-2336.2004 · Cited by 43
Yang, Y., & Bush, K. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08105.x · Cited by 38
Nagano, R., Adachi, Y., Hashizume, T., & Morishima, H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.3.271 · Cited by 36
Changes in zinc ligation promote remodeling of the active site in the zinc hydrolase superfamily.
Wouters, M. A., & Husain, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.5161 · Cited by 35
Bellais, S., Mimoz, O., Léotard, S., Jacolot, A., Petitjean, O., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.2032-2034.2002 · Cited by 35
Self-citation
Cited by
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Self-citationCarbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, P., Naas, T., & Poirel, L. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1710.110655 · Cited by 2,378
Self-citation
Metadata
- Authors
- Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2005-04
- Volume
- 18
- Issue
- 2
- Pages
- 306-325
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2171000901
- Cited by
- 1,431
- References
- 99
- FWCI
- 46.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.